Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis

Background: International treatment guidelines for Helicobacter pylori infection recommend a proton pump inhibitor (PPI)/amoxicillin/clarithromycin (CAM) regimen (PAC) or PPI/amoxicillin/metronidazole (MNZ) regimen (PAM) as first-line therapy based on culture and sensitivity testing. As incidence ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Masaki, Sugimoto, Mitsushige, Mizuno, Hitomi, Kanno, Takeshi, Satoh, Kiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073899/
https://www.ncbi.nlm.nih.gov/pubmed/32079208
http://dx.doi.org/10.3390/jcm9020543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073899/
https://www.ncbi.nlm.nih.gov/pubmed/32079208
http://dx.doi.org/10.3390/jcm9020543

Ejemplares similares